CLOSTRIDIOIDES DIFFICILE INFECTION
Clinical trials for CLOSTRIDIOIDES DIFFICILE INFECTION explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIOIDES DIFFICILE INFECTION trials appear
Sign up with your email to follow new studies for CLOSTRIDIOIDES DIFFICILE INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria capsules take on superbugs in antibiotic patients
Disease control CompletedThis study tested whether taking capsules containing healthy gut bacteria could help clear drug-resistant germs from the intestines of patients on long-term antibiotics. 42 hospitalized adults received either the bacteria capsules or a placebo. The main goal was to see if the ger…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated May 17, 2026 10:27 UTC
-
New drug shows promise in fighting deadly gut infection
Disease control CompletedThis study tested whether adding the drug bezlotoxumab to standard treatment could help people with a serious gut infection called C. diff. The trial included 44 adults at high risk for complications like organ failure, relapse, or death. Researchers used a special score to ident…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE2 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New antibiotic shows promise against stubborn gut infection
Disease control CompletedThis study tested a new antibiotic called CRS3123 against a standard treatment (vancomycin) for adults with a C. diff infection, a serious gut infection that causes severe diarrhea. The goal was to see if CRS3123 is safe and effective at stopping the infection. About 43 adults wi…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE2 • Sponsor: Crestone, Inc • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
Early safety check for potential c. diff drug in japanese volunteers
Knowledge-focused CompletedThis study tested a single dose of a new drug called AZD5148 in 16 healthy Japanese adults to see if it is safe and how the body processes it. The drug is being developed for Clostridioides difficile infection. Participants received either the drug or a placebo by injection. The …
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 10:26 UTC